U.K. Big Pharma, Big Dividends

Hikma Pharmaceuticals

Market Cap: UK£2.7b

Develops, manufactures, markets, and sells a range of generic, branded, and in-licensed pharmaceutical products.

AstraZeneca

Market Cap: UK£234.0b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

GSK

Market Cap: UK£84.8b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.